Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusResearch in context

Summary: Background: Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease affecting multiple organs and tissues with high cellular heterogeneity. CD8+ T cell activity is involved in the SLE pathogenesis. However, the cellular heterogeneity and the underlying mechanisms of CD8+ T...

Full description

Bibliographic Details
Main Authors: Hui Xiong, Mintian Cui, Ni Kong, Jiongjie Jing, Ying Xu, Xiuting Liu, Fan Yang, Zhen Xu, Yu Yan, Dongyang Zhao, Ziqi Zou, Meng Xia, Junjie Cen, Guozhen Tan, Cong Huai, Qiong Fu, Qing Guo, Kun Chen
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396423000725
_version_ 1811158417686921216
author Hui Xiong
Mintian Cui
Ni Kong
Jiongjie Jing
Ying Xu
Xiuting Liu
Fan Yang
Zhen Xu
Yu Yan
Dongyang Zhao
Ziqi Zou
Meng Xia
Junjie Cen
Guozhen Tan
Cong Huai
Qiong Fu
Qing Guo
Kun Chen
author_facet Hui Xiong
Mintian Cui
Ni Kong
Jiongjie Jing
Ying Xu
Xiuting Liu
Fan Yang
Zhen Xu
Yu Yan
Dongyang Zhao
Ziqi Zou
Meng Xia
Junjie Cen
Guozhen Tan
Cong Huai
Qiong Fu
Qing Guo
Kun Chen
author_sort Hui Xiong
collection DOAJ
description Summary: Background: Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease affecting multiple organs and tissues with high cellular heterogeneity. CD8+ T cell activity is involved in the SLE pathogenesis. However, the cellular heterogeneity and the underlying mechanisms of CD8+ T cells in SLE remain to be identified. Methods: Single-cell RNA sequencing (scRNA-seq) of PBMCs from a SLE family pedigree (including 3 HCs and 2 SLE patients) was performed to identify the SLE-associated CD8+ T cell subsets. Flow cytometry analysis of a SLE cohort (including 23 HCs and 33 SLE patients), qPCR analysis of another SLE cohort (including 30 HCs and 25 SLE patients) and public scRNA-seq datasets of autoimmune diseases were employed to validate the finding. Whole-exome sequencing (WES) of this SLE family pedigree was used to investigate the genetic basis in dysregulation of CD8+ T cell subsets identified in this study. Co-culture experiments were performed to analyze the activity of CD8+ T cells. Findings: We elucidated the cellular heterogeneity of SLE and identified a new highly cytotoxic CD8+ T cell subset, CD161−CD8+ TEMRA cell subpopulation, which was remarkably increased in SLE patients. Meanwhile, we discovered a close correlation between mutation of DTHD1 and the abnormal accumulation of CD161−CD8+ TEMRA cells in SLE. DTHD1 interacted with MYD88 to suppress its activity in T cells and DTHD1 mutation promoted MYD88-dependent pathway and subsequently increased the proliferation and cytotoxicity of CD161−CD8+ TEMRA cells. Furthermore, the differentially expressed genes in CD161−CD8+ TEMRA cells displayed a strong out-of-sample prediction for case–control status of SLE. Interpretation: This study identified DTHD1-associated expansion of CD161−CD8+ TEMRA cell subpopulation is critical for SLE. Our study highlights genetic association and cellular heterogeneity of SLE pathogenesis and provides a mechanistical insight into the diagnosis and treatment of SLE. Fundings: Stated in the Acknowledgements section of the manuscript.
first_indexed 2024-04-10T05:23:11Z
format Article
id doaj.art-06ef090c1532479494a64f8f0ea5497a
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-04-10T05:23:11Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-06ef090c1532479494a64f8f0ea5497a2023-03-08T04:14:28ZengElsevierEBioMedicine2352-39642023-04-0190104507Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusResearch in contextHui Xiong0Mintian Cui1Ni Kong2Jiongjie Jing3Ying Xu4Xiuting Liu5Fan Yang6Zhen Xu7Yu Yan8Dongyang Zhao9Ziqi Zou10Meng Xia11Junjie Cen12Guozhen Tan13Cong Huai14Qiong Fu15Qing Guo16Kun Chen17Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, ChinaTranslational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, ChinaTranslational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, ChinaTranslational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, ChinaDepartment of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, ChinaTranslational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, ChinaTranslational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, ChinaTranslational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, ChinaDepartment of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, ChinaInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, 310058, ChinaInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, 310058, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, ChinaBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, ChinaDepartment of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200127, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China; Corresponding author.Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China; Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China; Corresponding author. Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China.Summary: Background: Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease affecting multiple organs and tissues with high cellular heterogeneity. CD8+ T cell activity is involved in the SLE pathogenesis. However, the cellular heterogeneity and the underlying mechanisms of CD8+ T cells in SLE remain to be identified. Methods: Single-cell RNA sequencing (scRNA-seq) of PBMCs from a SLE family pedigree (including 3 HCs and 2 SLE patients) was performed to identify the SLE-associated CD8+ T cell subsets. Flow cytometry analysis of a SLE cohort (including 23 HCs and 33 SLE patients), qPCR analysis of another SLE cohort (including 30 HCs and 25 SLE patients) and public scRNA-seq datasets of autoimmune diseases were employed to validate the finding. Whole-exome sequencing (WES) of this SLE family pedigree was used to investigate the genetic basis in dysregulation of CD8+ T cell subsets identified in this study. Co-culture experiments were performed to analyze the activity of CD8+ T cells. Findings: We elucidated the cellular heterogeneity of SLE and identified a new highly cytotoxic CD8+ T cell subset, CD161−CD8+ TEMRA cell subpopulation, which was remarkably increased in SLE patients. Meanwhile, we discovered a close correlation between mutation of DTHD1 and the abnormal accumulation of CD161−CD8+ TEMRA cells in SLE. DTHD1 interacted with MYD88 to suppress its activity in T cells and DTHD1 mutation promoted MYD88-dependent pathway and subsequently increased the proliferation and cytotoxicity of CD161−CD8+ TEMRA cells. Furthermore, the differentially expressed genes in CD161−CD8+ TEMRA cells displayed a strong out-of-sample prediction for case–control status of SLE. Interpretation: This study identified DTHD1-associated expansion of CD161−CD8+ TEMRA cell subpopulation is critical for SLE. Our study highlights genetic association and cellular heterogeneity of SLE pathogenesis and provides a mechanistical insight into the diagnosis and treatment of SLE. Fundings: Stated in the Acknowledgements section of the manuscript.http://www.sciencedirect.com/science/article/pii/S2352396423000725Systemic lupus erythematosusscRNA-seqWhole-exome sequencingCD8+ T cell subsetGenetic variantDTHD1
spellingShingle Hui Xiong
Mintian Cui
Ni Kong
Jiongjie Jing
Ying Xu
Xiuting Liu
Fan Yang
Zhen Xu
Yu Yan
Dongyang Zhao
Ziqi Zou
Meng Xia
Junjie Cen
Guozhen Tan
Cong Huai
Qiong Fu
Qing Guo
Kun Chen
Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusResearch in context
EBioMedicine
Systemic lupus erythematosus
scRNA-seq
Whole-exome sequencing
CD8+ T cell subset
Genetic variant
DTHD1
title Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusResearch in context
title_full Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusResearch in context
title_fullStr Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusResearch in context
title_full_unstemmed Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusResearch in context
title_short Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusResearch in context
title_sort cytotoxic cd161 cd8 temra cells contribute to the pathogenesis of systemic lupus erythematosusresearch in context
topic Systemic lupus erythematosus
scRNA-seq
Whole-exome sequencing
CD8+ T cell subset
Genetic variant
DTHD1
url http://www.sciencedirect.com/science/article/pii/S2352396423000725
work_keys_str_mv AT huixiong cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT mintiancui cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT nikong cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT jiongjiejing cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT yingxu cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT xiutingliu cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT fanyang cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT zhenxu cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT yuyan cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT dongyangzhao cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT ziqizou cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT mengxia cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT junjiecen cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT guozhentan cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT conghuai cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT qiongfu cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT qingguo cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext
AT kunchen cytotoxiccd161cd8temracellscontributetothepathogenesisofsystemiclupuserythematosusresearchincontext